Valneva SE (VALN) Net Cash Flow (2021 - 2026)

Valneva SE (VALN) posted quarterly Net Cash Flow of -$5.4 million for Q1 2026, up 66.9% year-on-year from -$3.2 million in Q1 2025, and up 86.95% on a QoQ basis from -$41.2 million in Q4 2025.

Valneva SE (VALN) Net Cash Flow (2021 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Net Cash Flow for 6 consecutive years, with -$5.4 million the latest figure, recorded in Q1 2026.

  • Quarterly Net Cash Flow rose 66.9% year-over-year to -$5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$52.0 million (down 83.77% YoY) and the FY2025 annual result came in at -$62.8 million, down 236.76% from the prior year.
  • Net Cash Flow rose to -$5.4 million in Q1 2026 per VALN's latest filing, from -$41.2 million in the prior quarter.
  • Over the last five years, Net Cash Flow for VALN reached as high as $91.9 billion in Q3 2023 and fell as low as -$92.0 billion in Q2 2023.
  • A 5-year average of -$16.0 million and a median of -$16.2 million in 2025 frame the typical range for Net Cash Flow.
  • The largest YoY upside for Net Cash Flow was 102503.4% in 2023 against a maximum downside of 324623.36% in 2023.
  • Year by year, Net Cash Flow stood at $34.1 million in 2022, then plunged by 253.97% to -$52.6 million in 2023, then jumped by 117.46% to $9.2 million in 2024, then sank by 548.86% to -$41.2 million in 2025, then jumped by 86.95% to -$5.4 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$5.4 million, -$41.2 million, and -$18.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 10.56 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 224.46 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.34 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 457.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -152.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 57.19 Mn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn -5.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.38 Mn
Mar 31, 2026 -5.38 Mn
Dec 31, 2025 -41.20 Mn
Dec 31, 2025 -41.20 Mn
Sep 30, 2025 -18.56 Mn
Sep 30, 2025 -18.56 Mn
Jun 30, 2025 13.16 Mn
Jun 30, 2025 13.16 Mn
Mar 31, 2025 -16.25 Mn
Mar 31, 2025 -16.25 Mn
Dec 31, 2024 9.18 Mn
Dec 31, 2024 9.18 Mn
Sep 30, 2024 30.10 Mn
Sep 30, 2024 30.10 Mn
Jun 30, 2024 -51.31 Mn
Jun 30, 2024 -51.31 Mn
Mar 31, 2024 57.98 Mn
Mar 31, 2024 57.98 Mn
Dec 31, 2023 -52.57 Mn
Dec 31, 2023 -52.57 Mn